Novavax seeks approval in Australia as Indonesia gives green light

Novavax has completed it’s application to the Australian Therapeutic Goods Administration for provisional approval.

If successful, the vaccine would be the fourth approved jab in Australia, after AstraZeneca, Pfizer and Moderna.

It would also become the first protein-based vaccination…

Click here to view the original article.